India to Saudi Arabia: Everolimus Export Trade Route
India has recorded 11 verified shipments of Everolimus exported to Saudi Arabia, representing a combined trade value of $2.6M USD. This corridor is served by 3 active Indian exporters, with an average shipment value of $234.4K USD. The leading Indian exporter is NATCO PHARMA LIMITED, which accounts for 100% of total export value with 6 shipments worth $2.6M USD. On the buying side, BOSTON ONCOLOGY ARABIA is the largest importer in Saudi Arabia with $2.6M USD in purchases. The top 3 suppliers — NATCO PHARMA LIMITED, STARCELL BIOTECH LLP, MODERN DRUG HOUSE — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Saudi Arabia Everolimus corridor is one of India's established pharmaceutical export routes, with 11 shipments documented worth a combined $2.6M USD. The route is dominated by NATCO PHARMA LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's everolimus manufacturing sector.
Across 3 active suppliers, the average shipment value stands at $234.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (69%) and air (18%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during January–March, with an average transit time of 16 days port-to-port. The route has recorded an annual growth rate of 10.6%, placing it at rank #8 among India's top everolimus export destinations globally.
On the import side, key buyers of Indian everolimus in Saudi Arabia include BOSTON ONCOLOGY ARABIA, M/S ARABIAN OASIS COMPANY, TO THE ORDER OF-. BOSTON ONCOLOGY ARABIA is the single largest importer with 6 shipments valued at $2.6M USD.
Route Characteristics
- Average transit16 days
- Peak seasonQ1
- Primary modeMulti-modal
- Top portSAHAR AIR CARGO ACC (INBOM4)
Market Position
- Global rank#8
- Annual growth+10.6%
- Demand growth+10.4%
- Regulatory ease70/100
Top 10 Indian Everolimus Exporters to Saudi Arabia
Showing top 10 of 3 Indian suppliers exporting Everolimus to Saudi Arabia, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | NATCO PHARMA LIMITED Avg $428.5K per shipment | 6 | $2.6M | 99.7% |
| 2 | STARCELL BIOTECH LLP Avg $2.6K per shipment | 2 | $5.1K | 0.2% |
| 3 | MODERN DRUG HOUSE Avg $879 per shipment | 3 | $2.6K | 0.1% |
This table shows the top 10 of 3 Indian companies exporting everolimus to Saudi Arabia, ranked by total trade value. The listed exporters are: NATCO PHARMA LIMITED, STARCELL BIOTECH LLP, MODERN DRUG HOUSE. NATCO PHARMA LIMITED is the dominant supplier with 6 shipments worth $2.6M USD, giving it a 100% market share.
Top 10 Everolimus Importers in Saudi Arabia
Showing top 10 of 3 known buyers in Saudi Arabia receiving Everolimus shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian everolimus in Saudi Arabia include BOSTON ONCOLOGY ARABIA, M/S ARABIAN OASIS COMPANY, TO THE ORDER OF-. The largest importer is BOSTON ONCOLOGY ARABIA, accounting for $2.6M USD across 6 shipments — representing 100% of all everolimus imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | BOSTON ONCOLOGY ARABIA | 6 | $2.6M | 99.7% |
| 2 | M/S ARABIAN OASIS COMPANY | 2 | $5.1K | 0.2% |
| 3 | TO THE ORDER OF- | 3 | $2.6K | 0.1% |
Top 10 Everolimus Formulations Imported by Saudi Arabia
Showing top 10 of 9 product formulations shipped on the India to Saudi Arabia Everolimus route, ranked by trade value
Saudi Arabia imports a wide range of everolimus formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — EVEROLIMUS 5MG TABLET APPENDIX 4R RODTEP ENTRY NO 10112 OUR REFERENCE S CI NO 125026 — accounts for $1.0M USD across 1 shipments. A total of 9 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | EVEROLIMUS 5MG TABLET APPENDIX 4R RODTEP ENTRY NO 10112 OUR REFERENCE S CI NO 125026 | 1 | $1.0M | 39.8% |
| 2 | EVEROLIMUS 10MG TABLET APPENDIX 4R RODTEP ENTRY NO 10112 OUR REFERENCE S CINO 125026 | 1 | $693.8K | 26.9% |
| 3 | EVEROLIMUS 5MG TABLET (APPENDIX 4R,ROTEPENTRY NO: 10112) OUR REF CI NO:124265) | 1 | $282.5K | 11.0% |
| 4 | EVEROLIMUS 5MG TABLETS(APPENDIX 4R RODTEP ENTRY NO:10112)(OTHER REFERENCE CI NO:124050) | 1 | $242.8K | 9.4% |
| 5 | EVEROLIMUS 10MG TABLET (APPENDIX 4R,ROTEP ENTRY NO: 10112) OUR REF CI NO:124265) | 1 | $167.6K | 6.5% |
| 6 | EVEROLIMUS 10MG TABLETS(APPENDIX 4R RODTEP ENTRY NO:10112)(OTHER REFERENCE CINO:124050) | 1 | $156.8K | 6.1% |
| 7 | CERTICAN 0.75MG EVEROLIMUS TABLETS.EACHCAPSULE CONTAINS EVEROLIMUS 0.75MG) 6 X10 TABLETS PO NO: 0124 ? 121 STRIPS NUMB | 1 | $4.8K | 0.2% |
| 8 | PHARMACEUTICAL HARMLESS MEDICINES FOR HUMAN USE AS MENTIONED BELOW AS PER BUYERSORDER EVEROLIMUS TABLETS 0.25MG, STRIP | 3 | $2.6K | 0.1% |
| 9 | CERTICAN 0.25MG EVEROLIMUS TABLETS.EACHCAPSULE CONTAINS EVEROLIMUS 0.25MG) 6 X10 TABLETS PO NO: 0124 ? 20 STRIPS NUMBE | 1 | $299 | 0.0% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 69% sea for bulk, 18% air for urgent orders.
Top Ports of Origin
SAHAR AIR CARGO ACC (INBOM4) handles the highest volume with 3 shipments. Transit time averages 16 days by sea.
Market Dynamics
India's everolimus exports to Saudi Arabia are driven primarily by a handful of large-scale manufacturers. NATCO PHARMA LIMITED with 6 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in Saudi Arabia benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — NATCO PHARMA LIMITED, STARCELL BIOTECH LLP, MODERN DRUG HOUSE — together account for 100% of total trade value on this route. The average shipment value of $234.4K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as everolimus 10mg tablet appendix 4r rodtep entry no 10112 our reference s cino 125026 and everolimus 5mg tablet (appendix 4r,rotepentry no: 10112) our ref ci no:124265), suggesting that buyers in Saudi Arabia tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, BOSTON ONCOLOGY ARABIA is the largest importer with 6 shipments worth $2.6M USD — representing 100% of all everolimus imports from India on this route.
Route Statistics
- Trade Volume
- $2.6M
- Avg. Shipment
- $234.4K
- Suppliers
- 3
- Buyers
- 3
- Transit (Sea)
- ~16 days
- Annual Growth
- +10.6%
Related Analysis
Other Everolimus Routes
Unlock the Full India to Saudi Arabia Everolimus Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 11 shipments on this route.
Frequently Asked Questions — India to Saudi Arabia Everolimus Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Everolimus to Saudi Arabia?
The leading Indian exporters of Everolimus to Saudi Arabia are NATCO PHARMA LIMITED, STARCELL BIOTECH LLP, MODERN DRUG HOUSE. NATCO PHARMA LIMITED holds the largest market share at approximately 100% of total trade value on this route.
Q What is the total value of Everolimus exports from India to Saudi Arabia?
India exports Everolimus to Saudi Arabia worth approximately $2.6M USD across 11 recorded shipments. The average value per shipment is $234.4K USD.
Q Which ports does India use to ship Everolimus to Saudi Arabia?
The most active port of origin is SAHAR AIR CARGO ACC (INBOM4) with 3 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 69% of shipments going by sea and 18% by air.
Q How long does shipping take from India to Saudi Arabia for Everolimus?
The average transit time for Everolimus shipments from India to Saudi Arabia is approximately 16 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to Saudi Arabia Everolimus trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 10.6% with demand growth tracking at 10.4%. The route is ranked #8 among India's top Everolimus export destinations globally.
Q How many suppliers are active on the India to Saudi Arabia Everolimus route?
There are currently 3 active Indian suppliers exporting Everolimus to Saudi Arabia. The market is moderately concentrated with NATCO PHARMA LIMITED accounting for 100% of total shipment value.
Q Who are the main importers of Everolimus from India in Saudi Arabia?
The leading importers of Indian Everolimus in Saudi Arabia include BOSTON ONCOLOGY ARABIA, M/S ARABIAN OASIS COMPANY, TO THE ORDER OF-. BOSTON ONCOLOGY ARABIA is the largest buyer with 6 shipments worth $2.6M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Saudi Arabia export trade corridor identified from Indian Customs (DGFT) records for Everolimus.
- 2.Supplier/Buyer Matching: 3 Indian exporters and 3 importers in Saudi Arabia matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 11 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
11 Verified Shipments
3 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists